Journal profile · MEDICINE, RESEARCH & EXPERIMENTAL
Yonago acta medica
ISSN 0513-5710 · eISSN 1346-8049 · Tottori University Faculty of Medicine · JAPAN · Semiannual · Founded 1954
Yonago acta medica: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 1.03; fully open access; median 47 days to acceptance (78 articles, last 24 months); community-reported acceptance: easy; 39 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Yonago acta medica is published by Tottori University Faculty of Medicine and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Autism Spectrum Disorder Research, Liver Disease Diagnosis and Treatment and Gastric Cancer Management and Outcomes, together about 20% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
Yonago Acta Medica (YAM) is an electronic journal specializing in medical sciences, published by Tottori University Medical Press, 86 Nishi-cho, Yonago 683-8503, Japan. The subject areas cover the following: molecular/cell biology; biochemistry; basic medicine; clinical medicine; veterinary medicine; clinical nutrition and food sciences; medical engineering; nursing sciences; laboratory medicine; clinical psychology; medical education.
From the journal's Aims & Scope
Research area (LetPub): MEDICINE, RESEARCH & EXPERIMENTAL
Main research topics OpenAlex counts of recent articles; shares are approximate
- Autism Spectrum Disorder ResearchNeuroscience6.9%
- Liver Disease Diagnosis and TreatmentMedicine6.5%
- Gastric Cancer Management and OutcomesMedicine6.5%
- Pancreatic and Hepatic Oncology ResearchMedicine5.3%
- Inflammatory Biomarkers in Disease PrognosisMedicine5.3%
- Family and Disability Support ResearchPsychology4.9%
- Esophageal Cancer Research and TreatmentMedicine4.1%
- Gastrointestinal Tumor Research and TreatmentMedicine4.1%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Medicine, Research & Experimental | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Medicine, Research & Experimental | Zone 4 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Medicine, Research & Experimental | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
Web of SciencePMCPubMedPublisher website
Other: J-STAGE, Crossref, EBSCO, Medical*Online
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 1.03LetPub ·
- Impact factor (publisher) 2026
- 1Publisher website ·
- Impact factor (publisher) 2025
- 1Publisher website ·
- Impact factor (publisher) 2023
- 1Publisher website ·
- Impact factor (publisher) 2022
- 1.37Publisher website ·
- Impact factor (publisher) 2021
- 1.64Publisher website ·
- CiteScore 2026-06
- 1.5LetPub ·
- SJR 2026-06
- 0.28LetPub ·
- SNIP 2026-06
- 0.49LetPub ·
- h-index
- 14LetPub ·
- h-index
- 24OpenAlex ·
- i10-index
- 86OpenAlex ·
- 2-year mean citedness
- 1.55OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 100%LetPub ·
Volume
- Articles per year
- 39LetPub ·
- Articles per year (publisher)
- 2,023Publisher website ·
Articles by year OpenAlex count · 605 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 35 | 35 | 8 |
| 2025 | 39 | 39 | 43 |
| 2024 | 44 | 44 | 132 |
| 2023 | 64 | 64 | 178 |
| 2022 | 43 | 43 | 176 |
| 2021 | 48 | 48 | 355 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
47 daysMedian, submission to acceptance · P25–P75 28 days – 93 days
- Acceptance to online
- median 33 days (75 articles)
- Submission to online
- median 80 days
- Sample
- 78 articles with submission and acceptance dates (84 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- over 12 weeksLetPub ·
- Average acceptance (community reports)
- EasyLetPub ·
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessOpenAlex
Every article is open access; authors usually pay an article processing charge (APC).
No source has fee information yet; check the journal's website.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
Article types accepted4
- original articlesArticles are classified into four categories: review articles, original articles, patient reports, and short communications.Length not stated
- patient reportsArticles are classified into four categories: review articles, original articles, patient reports, and short communications.Length not stated
- review articlesArticles are classified into four categories: review articles, original articles, patient reports, and short communications.Length not stated
- short communicationsArticles are classified into four categories: review articles, original articles, patient reports, and short communications.Length not stated
Policy excerpts from the journal's websiteAuthorship, License & copyright
- Authorship
Submissions limited to members of Tottori University and Tottori University Hospital; external researchers may submit with recommendation from a professor, associate professor, or junior associate professor at this university community. Model summary
Basically, contributors are limited to members of Tottori University and Tottori University Hospital. Researchers outside the above-mentioned university community may also submit papers on the recommendation of a professor, an associate professor, or a junior associate professor at this university community.
Source ↗Publisher website ·- License & copyright Copyright permission request
日本国内の利用者の方へ ヨナゴ・アクタ・メディカ刊行会では複写複製および転載複製に係る著作権を学術著作権協会に委託しています。当該利用をご希望の方は、学術著作権協会（https://www.jaacc.org/）が提供している複製利用許諾システムもしくは転載許諾システムを通じて申請してください。 なお、Yonago Acta Medicaの著者またはヨナゴ・アクタ・メディカ刊行会会員（鳥取大学医学部教職員）に該当する方が非営利目的で転載利用を希望される場合には、無償でご利用いただくことが可能です。その場合は、直接、ヨナゴ・アクタ・メディカ刊行会までお問い合わせください。 To those who wish to obtain permission outside Japan Tottori University Medical Press has authorized the Japan …
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Tottori University Faculty of Medicine
- Country or region
- JAPAN
- Language
- English
- Frequency
- Semiannual
- Founded
- 1954
- ISSN
- 0513-5710
- Electronic ISSN
- 1346-8049
- Official links
- Journal homepage ↗LetPub
- Submission system ↗LetPub
FAQ
Frequently asked questions about Yonago acta medica
What CAS zone is Yonago acta medica in?
In the 2025 upgraded edition of the CAS Journal Ranking, Yonago acta medica is in Zone 4 of Medicine, and in Zone 4 of the minor category Medicine, Research & Experimental. In the 2026 Xinrui edition it is in Zone 4 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Yonago acta medica?
The latest impact factor listed by LetPub is 1.03; CiteScore 1.5, h-index 24.
How long does peer review take at Yonago acta medica?
Based on the dates recorded on 78 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 47 days (interquartile range 28–93 days); authors report an average review time of over 12 weeks; the community-reported acceptance is “Easy”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Which databases index Yonago acta medica?
According to LetPub and DOAJ records, Yonago acta medica is indexed in SCIE and Scopus. The journal's website also lists Web of Science, PMC and PubMed; that list has not been checked against each database.
Is Yonago acta medica open access, and what is the APC?
Yonago acta medica is a fully open-access journal. Fee information is not available yet; check the journal's website.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .